Lessons from a cardiovascular outcome trial with liraglutide in type 2 diabetes.

J Diabetes Investig · 2017 · PMC5497034 · PMID 27930863

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical increasing trendno p-value reported

The favorable, but not statistically significant effect on non‐fatal stroke in the LEADER trial (hazard ratio 0.89) contrasted with a numerical increasing trend in non‐fatal stroke (not significant, hazard ratio 1.24) in the EMPA‐REG OUTCOME trial.

also in 16 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.